Mitoxantrone

Results: 30



#Item
1Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators

Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulators

Add to Reading List

Source URL: www.hsc.nihr.ac.uk

Language: English
2Microsoft Word[removed]abiraterone ZYTIGA JANSSEN PSD[removed]FINAL.doc

Microsoft Word[removed]abiraterone ZYTIGA JANSSEN PSD[removed]FINAL.doc

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:22
3PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application

PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-11-10 21:39:36
4Microsoft Word - Abiraterone ZYTIGA Janssen Cilag PSD[removed]FINAL.doc

Microsoft Word - Abiraterone ZYTIGA Janssen Cilag PSD[removed]FINAL.doc

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:21
5Deciding on Motherhood For Women Living with MS FreecallTM[removed]www.msaustralia.org.au

Deciding on Motherhood For Women Living with MS FreecallTM[removed]www.msaustralia.org.au

Add to Reading List

Source URL: www.mssociety.org.au

Language: English - Date: 2012-08-27 22:12:46
6ORIGINAL CONTRIBUTION  High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis Douglas E. Gladstone, MD; Kenneth W. Zamkoff, MD; Lauren Krupp, MD; Robert Peyster, MD; Patrick Sibony, MD; Christoph

ORIGINAL CONTRIBUTION High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis Douglas E. Gladstone, MD; Kenneth W. Zamkoff, MD; Lauren Krupp, MD; Robert Peyster, MD; Patrick Sibony, MD; Christoph

Add to Reading List

Source URL: www.direct-ms.org

Language: English - Date: 2010-12-22 01:50:32
7Questions	
  to	
  Ask	
  Your	
  Doctor	
  –	
  Chemotherapy	
   	
   Questions to Ask Your Doctor Chemotherapy All the test results are in and so is the diagnosis: prostate cancer. What

Questions  to  Ask  Your  Doctor  –  Chemotherapy     Questions to Ask Your Doctor Chemotherapy All the test results are in and so is the diagnosis: prostate cancer. What

Add to Reading List

Source URL: www.prostate.net

Language: English - Date: 2013-09-11 06:51:22
8Issue 14 l[removed]l Disease courses in MS MSIF14 pp01 cover.indd 1

Issue 14 l[removed]l Disease courses in MS MSIF14 pp01 cover.indd 1

Add to Reading List

Source URL: www.msif.org

Language: English - Date: 2014-10-14 05:17:55
9July 2014  DISCLOSURES Writing and Development Team Kathleen Costello, MS, ANP – Nothing to disclose June Halper, MSN, APN-C – Consultant (CME): Biogen Idec

July 2014 DISCLOSURES Writing and Development Team Kathleen Costello, MS, ANP – Nothing to disclose June Halper, MSN, APN-C – Consultant (CME): Biogen Idec

Add to Reading List

Source URL: www.nationalmssociety.org

Language: English - Date: 2014-09-23 13:57:08
10Oncologic Drugs Advisory Committee Meeting Briefing Document  Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or

Oncologic Drugs Advisory Committee Meeting Briefing Document Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or

Add to Reading List

Source URL: www.fda.gov

Language: English